<DOC>
	<DOCNO>NCT02498236</DOCNO>
	<brief_summary>This study evaluate effect 8 dos intranasal oxytocin placebo two propose measure target engagement brain . The target ( 1 ) suppression particular wave form ( mu ) electroencephalogram ( EEG ) subject observe socially relevant form motion ( 2 ) pupil dilation subject identify face show different emotion .</brief_summary>
	<brief_title>Target Engagement Oxytocin : Dose Ranging Study</brief_title>
	<detailed_description>Subjects schizophrenia spectrum disorder randomly assign one 8 dos oxytocin . After screen informed consent subject receive either assign dose placebo . Thirty minute follow drug administration patient evaluate EEG pupillometry task follow two test evaluate social salience . One week later subject second challenge alternative ( drug placebo ) condition .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Schizophrenia , Schizoaffective Disorder , Delusional Disorder Able cooperate study procedures Serious medical condition substance use Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Psychosis</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Oxytocin</keyword>
</DOC>